Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Equity (2021 - 2022)

Historic Return on Equity for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to 0.05%.

  • Atea Pharmaceuticals' Return on Equity rose 100.0% to 0.05% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.05%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.19% for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Return on Equity is 0.05%, which was up 100.0% from 0.02% recorded in Q2 2022.
  • Atea Pharmaceuticals' 5-year Return on Equity high stood at 0.19% for Q4 2021, and its period low was 0.03% during Q4 2020.
  • Its 3-year average for Return on Equity is 0.06%, with a median of 0.05% in 2021.
  • Per our database at Business Quant, Atea Pharmaceuticals' Return on Equity soared by 2200bps in 2021 and then plummeted by -400bps in 2022.
  • Quarter analysis of 3 years shows Atea Pharmaceuticals' Return on Equity stood at 0.03% in 2020, then surged by 735bps to 0.19% in 2021, then plummeted by -71bps to 0.05% in 2022.
  • Its Return on Equity stands at 0.05% for Q3 2022, versus 0.02% for Q2 2022 and 0.07% for Q1 2022.